Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico
Clinical trials sponsored by Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico, explained in plain language.
-
Cancer combo trial for rare skin cancer pulled before starting
Disease control TerminatedThis study planned to test a combination of two drugs, pembrolizumab and lenvatinib, in people with classic Kaposi sarcoma that had not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemo. However, the study was w…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Which hormone combo do women prefer for endometriosis?
Symptom relief OngoingThis study looks at two different hormone treatments for endometriosis, a condition that causes pain and fertility problems. Researchers want to find out which combination of progestin and natural estrogen makes women more satisfied after 6 months. The study involves 138 women wh…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Massive hospital study reveals hidden kidney danger
Knowledge-focused OngoingThis study looks at medical records of 43,000 hospitalized patients to find out how often acute kidney injury (sudden kidney damage) happens during a hospital stay. Researchers will also check if patients who had kidney injury are more likely to die or be readmitted. The goal is …
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 26, 2026 03:02 UTC